Advertisement

Abstract

Dysregulation of brain serotonin contributes to many psychiatric disorders. Tryptophan hydroxylase-2 (Tph2), rather than Tph1, is preferentially expressed in the brain. We report a functional (C1473G) single-nucleotide polymorphism in mouse Tph2 that results in the substitution of Pro447 with Arg447 and leads to decreased serotonin levels in PC12 cells. Moreover, in BALB/cJ and DBA/2 mice that are homozygous for the 1473G allele, brain serotonin tissue content and synthesis are reduced in comparison to C57Bl/6 and 129X1/SvJ mice that are homozygous for the 1473C allele. Our data provide direct evidence for a fundamental role of Tph2 in brain serotonin synthesis.
Get full access to this article

View all available purchase options and get full access to this article.

Already a Subscriber?

Supplementary Material

File (zhang.som.pdf)

References and Notes

1
S. J. Bonasera, L. H. Tecott, Pharmacol. Ther.88, 133 (2000).
2
J. A. Gingrich, R. Hen, Psychopharmacology155, 1 (2001).
3
D. L. Murphy et al., Genes Brain Behav.2, 350 (2003).
4
D. J. Waltheret al., Science299, 76 (2003).
5
Materials and methods are available as supporting material on Science Online.
6
L. A. Greene, A. S. Tischler, Proc. Natl. Acad. Sci. U.S.A.73, 2424 (1976).
7
S. Ye, S. Dhillon, X. Ke, A. R. Collins, I. N. Day, Nucleic Acids Res.29, E88 (2001).
8
I. Lucki, A. Dalvi, A. J. Mayorga, Psychopharmacology155, 315 (2001).
9
X. Zhang, J. M. Beaulieu, T. D. Sotnikova, R. R. Gainetdinov, M. G. Caron, unpublished data.
10
R. R. Gainetdinovet al., Science283, 397 (1999).
11
Supported by NIH grant no. MH60451.

Information & Authors

Information

Published In

Science
Volume 305 | Issue 5681
9 July 2004

Submission history

Received: 4 March 2004
Accepted: 23 April 2004
Published in print: 9 July 2004

Permissions

Request permissions for this article.

Authors

Affiliations

Xiaodong Zhang
Howard Hughes Medical Institute Laboratory, Department of Cell Biology, and Center for Models of Human Disease, Institute for Genome Sciences and Policy, Box 3287, Duke University Medical Center, Durham, NC 27710, USA.
Jean-Martin Beaulieu
Howard Hughes Medical Institute Laboratory, Department of Cell Biology, and Center for Models of Human Disease, Institute for Genome Sciences and Policy, Box 3287, Duke University Medical Center, Durham, NC 27710, USA.
Tatyana D. Sotnikova
Howard Hughes Medical Institute Laboratory, Department of Cell Biology, and Center for Models of Human Disease, Institute for Genome Sciences and Policy, Box 3287, Duke University Medical Center, Durham, NC 27710, USA.
Raul R. Gainetdinov
Howard Hughes Medical Institute Laboratory, Department of Cell Biology, and Center for Models of Human Disease, Institute for Genome Sciences and Policy, Box 3287, Duke University Medical Center, Durham, NC 27710, USA.
Marc G. Caron*
Howard Hughes Medical Institute Laboratory, Department of Cell Biology, and Center for Models of Human Disease, Institute for Genome Sciences and Policy, Box 3287, Duke University Medical Center, Durham, NC 27710, USA.

Notes

* To whom correspondence should be addressed. E-mail: [email protected]

Metrics & Citations

Metrics

Article Usage
Altmetrics

Citations

Export citation

Select the format you want to export the citation of this publication.

View Options

Get Access

Log in to view the full text

AAAS Log in

AAAS login provides access to Science for AAAS members, and access to other journals in the Science family to users who have purchased individual subscriptions.

Log in via OpenAthens.
Log in via Shibboleth.
More options

Purchase digital access to this article

Download and print this article for your personal scholarly, research, and educational use.

Purchase this issue in print

Buy a single issue of Science for just $15 USD.

View options

PDF format

Download this article as a PDF file

Download PDF

Media

Figures

Multimedia

Tables

Share

Share

Share article link

Share on social media